Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Companies Weigh Growing Power of Cloud Providers Amid AI Boom
A wave of partnerships between AI model makers and cloud providers is leading tech chiefs to assess the benefits of convenience versus becoming too reliant
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
J&J Revenue Up on Surge in Heart Procedures
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link
Johnson & Johnson Rips Off the Kenvue Band-Aid
A surprisingly early distribution and a stretched valuation hit J&J’s consumer health arm hard. Source link
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products. Source link
Notable Thursday Option Activity: JNJ, TXN, BAC
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Johnson & Johnson (Symbol: JNJ), where a
Stocks Withstand Earnings-Day Declines From Goldman Sachs, Johnson & Johnson
Bank of America was among the other big companies reporting Tuesday. Source link
Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook
First-quarter earnings were largely wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments. Source link
Bank Failures Rattle Market for Short-Term Lending
The underpinnings of the financial system and corporate funding for companies including Duke Energy are still thawing after last month’s banking crisis. Source link
J&J's $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion
The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses. Source link